C2Dx Inc., a medical device company based in the U.S., has acquired the otolaryngology/head and neck surgery (“OHNS”) family of products from Cook Medical. These products provide minimally invasive procedures for ENT surgeons to help treat chronic ear disorders, nasal/sinus and skull base reconstruction, obstructive salivary disease and dysphagia.
The Cook products that will now be sold by C2Dx are: Biodesign Otologic, Sinonasal and Duraplasty Grafts, the Sialendoscopy product line and Hercules 100. This family of products joins C2Dx’s previous acquisition of the Shaw Scalpel (from Hemostatix) in 2022.
“Cook has done an excellent job establishing these products as reliable, high-quality solutions for ENT and head & neck focused procedures specifically, and we have enjoyed working with them on this transition,” said Kevin McLeod, Founder and CEO. “We are excited to increase the market penetration of these products through our deep and experienced sales organisation and the international distributor network.”
FURTHER INFORMATION:
C2Dx, Inc
T: + 1 888 902 2239
E: sales@c2dx.com
W: www.c2dx.com
